顯影劑的全球市場 - 至2022年的預測:碘，釓，鋇，微泡沫

一般認為全球顯影劑市場，從2017年的45億7000萬美元，到2022年到55億3000萬美元擴大。市場，2017年∼2022年的年複合成長率 (CAGR) 3.9％的成長預計。

本報告提供全球顯影劑市場相關調查分析，市場概要，產業趨勢，各市場區隔的市場分析，競爭情形，主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

• 顯影劑:市場概要
• 亞太地區的顯影劑市場:各類型
• 各地區概述:顯影劑市場
• 全球顯影劑市場:各適應症
• 全球顯影劑市場:各種模式

第5章 市場概要

• 簡介
• 市場動態
  • 促進因素
  • 阻礙因素
  • 機會
  • 課題

第6章 開發平台評估

• 簡介
• 由於顯影劑的臨床試驗
• 產品平台

第7章 顯影劑的全球市場:各類型

• 簡介
• 碘顯影劑
• 釓顯影劑
• 微泡沫顯影劑
• 鋇顯影劑

第8章 顯影劑的全球市場:各種模式

• 簡介
• X光掃描/CT
• MRI
• 超音波

第9章 顯影劑的全球市場:各適應症

• 簡介
• 心血管疾病
• 癌症
• 腸胃疾病
• 肌肉骨骼系統疾病
• 神經疾病
• 腎臟疾病

第10章 顯影劑的全球市場:各給藥途徑

• 簡介
• 血管內
• 口服
• 直腸
• 其他

第11章 顯影劑的全球市場:各應用

• 簡介
• 放射線科
• IVR
• IVC

第12章 顯影劑的全球市場:各地區

• 簡介
• 北美
• 歐洲
• 亞太地區
• 其他

第13章 競爭情形

• 概要
• 市場佔有率分析
• 競爭模式

第14章 企業簡介

• GE HEALTHCARE
• BAYER
• BRACCO IMAGING
• GUERBET
• LANTHEUS
• 第一三共
• UNIJULES LIFE SCIENCES
• SPAGO NANOMEDICAL
• J.B. CHEMICALS AND PHARMACEUTICALS
• MAGNUS HEALTH
• TAEJOON PHARM
• JODAS

第15章 附錄

"Contrast media/contrast agents market is projected to grow at a CAGR of 3.9%."

The global contrast media market is projected to reach USD 5.53 billion by 2022 from an estimated USD 4.57 billion in 2017, growing at a CAGR of 3.9% during the forecast period. The contrast media market has witnessed various advancements in products and their approvals to meet the needs of patients and radiologists worldwide. Growth in the market can primarily be attributed to factors such as increasing number of approvals for contrast agents and growing number of public & private diagnostic centers. The increasing number of research and funding activities for research of contrast agents and their applications provides immense opportunities for players in the contrast media market.

"The X-ray/CT procedures segment to hold the largest share of the market in 2017."

On the basis of modality, the market is segmented into X-ray/CT, MRI, and ultrasound procedures. In 2017, X-ray/CT procedures segment is expected to command the largest share of the global contrast media market. The large share of this segment can be attributed to the increasing number of CT examinations across the globe, coupled with advancements in CT imaging technologies.

"The cardiovascular disorders segment is projected to grow at the highest CAGR during the forecast period."

On the basis of indication, the market is categorized into cardiovascular disorders, cancer, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. The cardiovascular disorders segment is expected to grow at the highest CAGR during the forecast period. Improvements in cardiac MRI procedures in cath labs, favorable reimbursement policies for contrast media used in cardiovascular diagnosis, and strong healthcare infrastructure in developed countries are some of the factors driving this segment.

"Asia Pacific to witness the highest growth during the forecast period."

Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2017-2022. Factors such as increasing R&D investments and favorable demographic scenario in China, rising aging population and cancer incidence in Japan, growing investments in the Indian radiology market, and growing focus of market players & increasing government support in other APAC countries are driving the growth of the market in this region.

Break of primary participants was as mentioned below:

• By Company Type: Tier I: 55%, Tier II: 25%, Tier III: 20%
• By Designation: C-Level Executives: 43%, Directors: 32%, Others: 25%
• By Region: North America: 38%, Europe: 23%, Asia Pacific : 29%, RoW: 10%

In 2017, GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), and Guerbet (France) were the leading players in the contrast media market.

Research Coverage:

The report provides a picture of the market across different industry verticals and regions. It aims at estimating the market size and future growth potential of this market across different segments such as by type, modality, route of administration, indication, application, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, product pipeline, and key market strategies.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater share of the concerned market. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the contrast media market. The report analyzes the market on the basis of type, route of administration, modality, indication, and application

• Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, product approvals, and new product launches in the contrast media/contrast agents market

• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various contrast media/contrast agents across regions

• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the contrast media market

• Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the contrast media market

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. OBJECTIVES OF THE STUDY
• 1.2. MARKET DEFINITION
• 1.3. MARKET SCOPE
  • 1.3.1. MARKETS COVERED
  • 1.3.2. YEARS CONSIDERED FOR THE STUDY
• 1.4. CURRENCY
• 1.5. LIMITATIONS
• 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

• 2.1. RESEARCH DATA
  • 2.1.1. SECONDARY DATA
  • 2.1.2. PRIMARY DATA
    • 2.1.2.1. Key industry insights
• 2.2. MARKET SIZE ESTIMATION
• 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

• 3.1. INTRODUCTION

4. PREMIUM INSIGHTS

• 4.1. CONTRAST MEDIA/CONTRAST AGENTS: MARKET OVERVIEW
• 4.2. ASIA PACIFIC CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE AND COUNTRY
• 4.3. CONTRAST MEDIA/CONTRAST AGENTS MARKET: GEOGRAPHIC SNAPSHOT
• 4.4. GLOBAL CONTRAST MEDIA/CONTRAST AGENTS, BY INDICATION
• 4.5. GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY

5. MARKET OVERVIEW

• 5.1. INTRODUCTION
• 5.2. MARKET DYNAMICS
  • 5.2.1. DRIVERS
    • 5.2.1.1. Increasing number of public & private diagnostic centers
    • 5.2.1.2. Large number of approvals for contrast agents
  • 5.2.2. RESTRAINTS
    • 5.2.2.1. Side effects and allergic reactions associated with contrast agents
  • 5.2.3. OPPORTUNITIES
    • 5.2.3.1. Entry of generic contrast media products
    • 5.2.3.2. Increasing research activities for contrast agents
  • 5.2.4. CHALLENGES
    • 5.2.4.1. Technological advancements in imaging solutions
    • 5.2.4.2. Restriction and withdrawal of linear gadolinium-based contrast agents (GBCAs)

6. PIPELINE ASSESSMENT

• 6.1. INTRODUCTION
• 6.2. CLINICAL TRIALS USING CONTRAST MEDIA
• 6.3. PRODUCT PIPELINE

7. GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE

• 7.1. INTRODUCTION
• 7.2. IODINATED CONTRAST MEDIA
• 7.3. GADOLINIUM-BASED CONTRAST MEDIA
• 7.4. MICROBUBBLE CONTRAST MEDIA
• 7.5. BARIUM-BASED CONTRAST MEDIA

8. GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY

• 8.1. INTRODUCTION
• 8.2. X-RAY/CT
• 8.3. MAGNETIC RESONANCE IMAGING
• 8.4. ULTRASOUND

9. GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION

• 9.1. INTRODUCTION
• 9.2. CARDIOVASCULAR DISORDERS
• 9.3. CANCER
• 9.4. GASTROINTESTINAL DISORDERS
• 9.5. MUSCULOSKELETAL DISORDERS
• 9.6. NEUROLOGICAL DISORDERS
• 9.7. NEPHROLOGICAL DISORDERS

10. GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE

OF ADMINISTRATION 74

• 10.1. INTRODUCTION
• 10.2. INTRAVASCULAR
• 10.3. ORAL
• 10.4. RECTAL
• 10.5. OTHER ROUTES

11. GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION

• 11.1. INTRODUCTION
• 11.2. RADIOLOGY
• 11.3. INTERVENTIONAL RADIOLOGY
• 11.4. INTERVENTIONAL CARDIOLOGY

12. GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION

• 12.1. INTRODUCTION
• 12.2. NORTH AMERICA
  • 12.2.1. US
  • 12.2.2. CANADA
• 12.3. EUROPE
  • 12.3.1. GERMANY
  • 12.3.2. UK
  • 12.3.3. FRANCE
  • 12.3.4. REST OF EUROPE
• 12.4. ASIA PACIFIC
  • 12.4.1. CHINA
  • 12.4.2. JAPAN
  • 12.4.3. INDIA
  • 12.4.4. REST OF ASIA PACIFIC (ROAPAC)
• 12.5. REST OF THE WORLD (ROW)

13. COMPETITIVE LANDSCAPE

• 13.1. OVERVIEW
• 13.2. MARKET SHARE ANALYSIS
• 13.3. COMPETITIVE SCENARIO
  • 13.3.1. MARKET DEVELOPMENTS (REGULATORY AND PRODUCT APPROVALS)
  • 13.3.2. AGREEMENTS, COLLABORATIONS, CONTRACTS, AND PARTNERSHIPS
  • 13.3.3. EXPANSIONS
  • 13.3.4. MERGERS AND ACQUISITIONS
  • 13.3.5. OTHER STRATEGIES

14. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)^*

• 14.1. GE HEALTHCARE
• 14.2. BAYER
• 14.3. BRACCO IMAGING
• 14.4. GUERBET
• 14.5. LANTHEUS
• 14.6. DAIICHI SANKYO
• 14.7. UNIJULES LIFE SCIENCES
• 14.8. SPAGO NANOMEDICAL
• 14.9. J.B. CHEMICALS AND PHARMACEUTICALS
• 14.10. MAGNUS HEALTH
• 14.11. TAEJOON PHARM
• 14.12. JODAS

^*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

15. APPENDIX

• 15.1. INSIGHTS OF INDUSTRY EXPERTS
• 15.2. DISCUSSION GUIDE
• 15.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 15.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
• 15.5. AVAILABLE CUSTOMIZATIONS
• 15.6. RELATED REPORTS
• 15.7. AUTHOR DETAILS

LIST OF TABLES

• TABLE 1: INDICATIVE LIST OF RESEARCH STUDIES UNDERTAKEN BY RESEARCH INSTITUTES AND UNIVERSITIES
• TABLE 2: INDICATIVE LIST OF CLINICAL TRIALS CONDUCTED FOR CONTRAST MEDIA/ CONTRAST AGENTS
• TABLE 3: INDICATIVE LIST OF PRODUCT PIPELINE FOR CONTRAST MEDIA/CONTRAST AGENTS
• TABLE 4: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
• TABLE 5: IODINATED CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
• TABLE 6: GADOLINIUM-BASED CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
• TABLE 7: MICROBUBBLE CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
• TABLE 8: BARIUM-BASED CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
• TABLE 9: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
• TABLE 10: X-RAY/CT CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
• TABLE 11: MRI CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
• TABLE 12: ULTRASOUND CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
• TABLE 13: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2015-2022 (USD MILLION)
• TABLE 14: CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR CARDIOVASCULAR DISORDERS, BY REGION, 2015-2022 (USD MILLION)
• TABLE 15: CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR CANCER, BY REGION, 2015-2022 (USD MILLION)
• TABLE 16: CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR GASTROINTESTINAL DISORDERS, BY REGION, 2015-2022 (USD MILLION)
• TABLE 17: CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2015-2022 (USD MILLION)
• TABLE 18: CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2015-2022 (USD MILLION)
• TABLE 19: CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR NEPHROLOGICAL DISORDERS, BY REGION, 2015-2022 (USD MILLION)
• TABLE 20: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
• TABLE 21: INTRAVASCULAR CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
• TABLE 22: ORAL CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
• TABLE 23: RECTAL CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
• TABLE 24: OTHER CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
• TABLE 25: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
• TABLE 26: CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR RADIOLOGY, BY REGION, 2015-2022 (USD MILLION)
• TABLE 27: CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2015-2022 (USD MILLION)
• TABLE 28: CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2015-2022 (USD MILLION)
• TABLE 29: NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
• TABLE 30: NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
• TABLE 31: NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
• TABLE 32: NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
• TABLE 33: NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION, 2015-2022 (USD MILLION)
• TABLE 34: NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
• TABLE 35: US: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
• TABLE 36: US: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
• TABLE 37: US: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
• TABLE 38: US: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION, 2015-2022 (USD MILLION)
• TABLE 39: US: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
• TABLE 40: INDICATIVE LIST OF RESEARCH PROJECTS IN CANADA, 2014-2017
• TABLE 41: CANADA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
• TABLE 42: CANADA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
• TABLE 43: CANADA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
• TABLE 44: CANADA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION, 2015-2022 (USD MILLION)
• TABLE 45: CANADA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
• TABLE 46: EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
• TABLE 47: EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
• TABLE 48: EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
• TABLE 49: EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
• TABLE 50: EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION, 2015-2022 (USD MILLION)
• TABLE 51: EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
• TABLE 52: GERMANY: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
• TABLE 53: GERMANY: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
• TABLE 54: GERMANY: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
• TABLE 55: GERMANY: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION, 2015-2022 (USD MILLION)
• TABLE 56: GERMANY: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
• TABLE 57: UK: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
• TABLE 58: UK: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
• TABLE 59: UK: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
• TABLE 60: UK: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION, 2015-2022 (USD MILLION)
• TABLE 61: UK: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
• TABLE 62: FRANCE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
• TABLE 63: FRANCE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
• TABLE 64: FRANCE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
• TABLE 65: FRANCE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION, 2015-2022 (USD MILLION)
• TABLE 66: FRANCE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
• TABLE 67: ROE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
• TABLE 68: ROE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
• TABLE 69: ROE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
• TABLE 70: ROE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION 2015-2022 (USD MILLION)
• TABLE 71: ROE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
• TABLE 72: ASIA PACIFIC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
• TABLE 73: ASIA PACIFIC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY , 2015-2022 (USD MILLION)
• TABLE 74: ASIA PACIFIC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
• TABLE 75: ASIA PACIFIC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
• TABLE 76: ASIA PACIFIC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION 2015-2022 (USD MILLION)
• TABLE 77: ASIA PACIFIC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
• TABLE 78: CHINA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
• TABLE 79: CHINA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
• TABLE 80: CHINA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
• TABLE 81: CHINA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION 2015-2022 (USD MILLION)
• TABLE 82: CHINA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
• TABLE 83: JAPAN: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
• TABLE 84: JAPAN: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
• TABLE 85: JAPAN: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
• TABLE 86: JAPAN: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION 2015-2022 (USD MILLION)
• TABLE 87: JAPAN: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
• TABLE 88: INDIA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
• TABLE 89: INDIA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
• TABLE 90: INDIA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
• TABLE 91: INDIA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION 2015-2022 (USD MILLION)
• TABLE 92: INDIA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
• TABLE 93: ROAPAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
• TABLE 94: ROAPAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
• TABLE 95: ROAPAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
• TABLE 96: ROAPAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION 2015-2022 (USD MILLION)
• TABLE 97: ROAPAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
• TABLE 98: ROW: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
• TABLE 99: ROW: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
• TABLE 100: ROW: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
• TABLE 101: ROW: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION, 2015-2022 (USD MILLION)
• TABLE 102: ROW: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
• TABLE 103: MARKET DEVELOPMENTS (REGULATORY AND PRODUCT APPROVALS)
• TABLE 104: AGREEMENTS, COLLABORATIONS, CONTRACTS, AND PARTNERSHIPS
• TABLE 105: EXPANSIONS
• TABLE 106: MERGERS AND ACQUISITIONS
• TABLE 107: OTHER STRATEGIES

LIST OF FIGURES

• FIGURE 1: GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET SEGMENTATION
• FIGURE 2: RESEARCH METHODOLOGY: GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET
• FIGURE 3: RESEARCH DESIGN
• FIGURE 4: KEY DATA FROM PRIMARY SOURCES
• FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• FIGURE 6: SAMPLING FRAME: PRIMARY RESEARCH
• FIGURE 7: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
• FIGURE 8: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
• FIGURE 9: DATA TRIANGULATION METHODOLOGY
• FIGURE 10: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY (2017)
• FIGURE 11: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017 VS. 2022
• FIGURE 12: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017 VS. 2022
• FIGURE 13: CONTRAST MEDIA/CONTRAST AGENTS MARKET ANALYSIS, BY APPLICATION, 2017 VS. 2022
• FIGURE 14: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017 VS. 2022
• FIGURE 15: ASIA PACIFIC CONTRAST MEDIA/CONTRAST AGENTS MARKET TO RECORD HIGHEST GROWTH DURING FORECAST PERIOD
• FIGURE 16: NORTH AMERICA TO HOLD LARGEST MARKET SHARE IN 2017
• FIGURE 17: IODINATED CONTRAST MEDIA AND JAPAN TO HOLD LARGEST MARKET SHARES IN 2017
• FIGURE 18: CHINA TO RECORD HIGHEST GROWTH DURING FORECAST PERIOD
• FIGURE 19: CARDIOVASCULAR DISORDERS TO HOLD LARGEST MARKET SHARE DURING FORECAST PERIOD
• FIGURE 20: X-RAY/CT PROCEDURES TO HOLD LARGEST MARKET SHARE IN 2017
• FIGURE 21: CONTRAST MEDIA/CONTRAST AGENTS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 22: CLINICAL TRIALS FOR CONTRAST MEDIA/CONTRAST AGENTS, BY PHASE (2014 ONWARDS)
• FIGURE 23: CLINICAL TRIALS FOR CONTRAST MEDIA/CONTRAST AGENTS, BY INDICATION (2014 ONWARDS)
• FIGURE 24: MICROBUBBLE CONTRAST MEDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
• FIGURE 25: ULTRASOUND SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
• FIGURE 26: CARDIOVASCULAR DISORDERS TO DOMINATE CONTRAST MEDIA/CONTRAST AGENTS MARKET IN 2017
• FIGURE 27: INTRAVASCULAR ROUTE OF ADMINISTRATION TO RECORD HIGHEST GROWTH DURING FORECAST PERIOD
• FIGURE 28: RADIOLOGY APPLICATION SEGMENT TO HOLD LARGEST MARKET SHARE IN 2017
• FIGURE 29: NORTH AMERICA TO HOLD LARGEST SHARE OF GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET IN 2017
• FIGURE 30: NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET SNAPSHOT
• FIGURE 31: PREVALENCE OF ALZHEIMER'S DISEASE IN THE US, BY AGE GROUP, 2015
• FIGURE 32: EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET SNAPSHOT
• FIGURE 33: ASIA PACIFIC: CONTRAST MEDIA /CONTRAST AGENTS MARKET SNAPSHOT
• FIGURE 34: ROW: CONTRAST MEDIA /CONTRAST AGENTS MARKET SNAPSHOT
• FIGURE 35: GLOBAL CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2016
• FIGURE 36: KEY GROWTH STRATEGIES ADOPTED BY PLAYERS IN CONTRAST MEDIA/CONTRAST AGENTS MARKET (2014-2017)
• FIGURE 37: GE HEALTHCARE: COMPANY SNAPSHOT
• FIGURE 38: BAYER: COMPANY SNAPSHOT
• FIGURE 39: GUERBET GROUP: COMPANY SNAPSHOT
• FIGURE 40: LANTHEUS: COMPANY SNAPSHOT
• FIGURE 41: DAIICHI SANKYO: COMPANY SNAPSHOT
• FIGURE 42: SPAGO NANOMEDICAL: COMPANY SNAPSHOT
• FIGURE 43: J.B. CHEMICALS AND PHARMACEUTICALS: COMPANY SNAPSHOT